Stocks
CASI PHARMACEUTICALS INCCASI
HealthcareBiotechnology
A biopharmaceutical company focused on acquiring, developing, and commercializing innovative therapeutics and drugs in the U.S. and China, with a pipeline targeting oncology and other serious diseases. Its lead product, ZEVALIN, is a CD20-directed radiotherapeutic for certain non-Hodgkin lymphomas, and it also markets other oncology products in China. Investors track CASI for its commercial presence in the Chinese pharmaceutical market and its late-stage pipeline.
Congressional Interest in CASI PHARMACEUTICALS INC (CASI)
No congressional trades have been disclosed for CASI PHARMACEUTICALS INC (CASI) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading CASI?
No congressional trades found for this stock.